196 related articles for article (PubMed ID: 21755948)
1. Conformationally constrained peptides from CD2 to modulate protein-protein interactions between CD2 and CD58.
Gokhale A; Weldeghiorghis TK; Taneja V; Satyanarayanajois SD
J Med Chem; 2011 Aug; 54(15):5307-19. PubMed ID: 21755948
[TBL] [Abstract][Full Text] [Related]
2. A peptide from the beta-strand region of CD2 protein that inhibits cell adhesion and suppresses arthritis in a mouse model.
Satyanarayanajois SD; Büyüktimkin B; Gokhale A; Ronald S; Siahaan TJ; Latendresse JR
Chem Biol Drug Des; 2010 Sep; 76(3):234-44. PubMed ID: 20572813
[TBL] [Abstract][Full Text] [Related]
3. Immunosuppression by co-stimulatory molecules: inhibition of CD2-CD48/CD58 interaction by peptides from CD2 to suppress progression of collagen-induced arthritis in mice.
Gokhale A; Kanthala S; Latendresse J; Taneja V; Satyanarayanajois S
Chem Biol Drug Des; 2013 Jul; 82(1):106-18. PubMed ID: 23530775
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity studies of peptides from the "hot-spot" region of human CD2 protein: development of peptides for immunomodulation.
Liu J; Ying J; Chow VT; Hruby VJ; Satyanarayanajois SD
J Med Chem; 2005 Oct; 48(20):6236-49. PubMed ID: 16190751
[TBL] [Abstract][Full Text] [Related]
5. Design of beta-hairpin peptides for modulation of cell adhesion by beta-turn constraint.
Giddu S; Subramanian V; Yoon HS; Satyanarayanajois SD
J Med Chem; 2009 Feb; 52(3):726-36. PubMed ID: 19123855
[TBL] [Abstract][Full Text] [Related]
6. Structure-based rational design of beta-hairpin peptides from discontinuous epitopes of cluster of differentiation 2 (CD2) protein to modulate cell adhesion interaction.
Liu J; Li C; Ke S; Satyanarayanajois SD
J Med Chem; 2007 Aug; 50(17):4038-47. PubMed ID: 17658775
[TBL] [Abstract][Full Text] [Related]
7. Constrained Cyclic Peptides as Immunomodulatory Inhibitors of the CD2:CD58 Protein-Protein Interaction.
Sable R; Durek T; Taneja V; Craik DJ; Pallerla S; Gauthier T; Jois S
ACS Chem Biol; 2016 Aug; 11(8):2366-74. PubMed ID: 27337048
[TBL] [Abstract][Full Text] [Related]
8. Investigating cyclic peptides inhibiting CD2-CD58 interactions through molecular dynamics and molecular docking methods.
Leherte L; Petit A; Jacquemin D; Vercauteren DP; Laurent AD
J Comput Aided Mol Des; 2018 Nov; 32(11):1295-1313. PubMed ID: 30368623
[TBL] [Abstract][Full Text] [Related]
9. Modulation of co-stimulatory signal from CD2-CD58 proteins by a grafted peptide.
Parajuli P; Sable R; Shrestha L; Dahal A; Gauthier T; Taneja V; Jois S
Chem Biol Drug Des; 2021 Mar; 97(3):607-627. PubMed ID: 32946175
[TBL] [Abstract][Full Text] [Related]
10. Design, structure and biological activity of beta-turn peptides of CD2 protein for inhibition of T-cell adhesion.
Jining L; Makagiansar I; Yusuf-Makagiansar H; Chow VT; Siahaan TJ; Jois SD
Eur J Biochem; 2004 Jul; 271(14):2873-86. PubMed ID: 15233784
[TBL] [Abstract][Full Text] [Related]
11. Structure-based identification of inhibitors disrupting the CD2-CD58 interactions.
Tripathi N; Leherte L; Vercauteren DP; Laurent AD
J Comput Aided Mol Des; 2021 Mar; 35(3):337-353. PubMed ID: 33532888
[TBL] [Abstract][Full Text] [Related]
12. Heterotypic cell adhesion assay for the study of cell adhesion inhibition.
Satyanarayanajois SD; Ronald S; Liu J
Methods Mol Biol; 2011; 716():225-43. PubMed ID: 21318910
[TBL] [Abstract][Full Text] [Related]
13. Mutational analysis of the CD2/CD58 interaction: the binding site for CD58 lies on one face of the first domain of human CD2.
Somoza C; Driscoll PC; Cyster JG; Williams AF
J Exp Med; 1993 Aug; 178(2):549-58. PubMed ID: 7688025
[TBL] [Abstract][Full Text] [Related]
14. Interaction between human CD2 and CD58 involves the major beta sheet surface of each of their respective adhesion domains.
Arulanandam AR; Kister A; McGregor MJ; Wyss DF; Wagner G; Reinherz EL
J Exp Med; 1994 Nov; 180(5):1861-71. PubMed ID: 7525842
[TBL] [Abstract][Full Text] [Related]
15. Crystal structure of the CD2-binding domain of CD58 (lymphocyte function-associated antigen 3) at 1.8-A resolution.
Ikemizu S; Sparks LM; van der Merwe PA; Harlos K; Stuart DI; Jones EY; Davis SJ
Proc Natl Acad Sci U S A; 1999 Apr; 96(8):4289-94. PubMed ID: 10200255
[TBL] [Abstract][Full Text] [Related]
16. Structure of a heterophilic adhesion complex between the human CD2 and CD58 (LFA-3) counterreceptors.
Wang JH; Smolyar A; Tan K; Liu JH; Kim M; Sun ZY; Wagner G; Reinherz EL
Cell; 1999 Jun; 97(6):791-803. PubMed ID: 10380930
[TBL] [Abstract][Full Text] [Related]
17. A novel, rapid and sensitive heterotypic cell adhesion assay for CD2-CD58 interaction, and its application for testing inhibitory peptides.
Liu J; Chow VT; Jois SD
J Immunol Methods; 2004 Aug; 291(1-2):39-49. PubMed ID: 15345303
[TBL] [Abstract][Full Text] [Related]
18. Costimulatory Function of Cd58/Cd2 Interaction in Adaptive Humoral Immunity in a Zebrafish Model.
Shao T; Shi W; Zheng JY; Xu XX; Lin AF; Xiang LX; Shao JZ
Front Immunol; 2018; 9():1204. PubMed ID: 29904386
[TBL] [Abstract][Full Text] [Related]
19. Topology of the CD2-CD48 cell-adhesion molecule complex: implications for antigen recognition by T cells.
van der Merwe PA; McNamee PN; Davies EA; Barclay AN; Davis SJ
Curr Biol; 1995 Jan; 5(1):74-84. PubMed ID: 7697352
[TBL] [Abstract][Full Text] [Related]
20. Impact of salt bridges on the equilibrium binding and adhesion of human CD2 and CD58.
Bayas MV; Kearney A; Avramovic A; van der Merwe PA; Leckband DE
J Biol Chem; 2007 Feb; 282(8):5589-96. PubMed ID: 17172599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
